EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Benzothiazole‐Based Anti‐Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025

Moksh Shah, Sudhanshu Sinha, Meetali Bhasme, Mange Ram Yadav iD, Afzal Nagani iD

The Chemical Record · 2026-06 · 26 (6)

DOI: 10.1002/tcr.70137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Chemical Record, online erschienen am 26.03.2026. Verfasst von Moksh Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Benzothiazoles, Cholinesterase Inhibitors, Neuroprotective Agents. Die Arbeit nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), a progressive neurodegenerative disorder, remains one of the greatest medical challenges because of its multifactorial nature. In recent years (2015–2025), benzothiazole‐based compounds have gained increasing attention as promising scaffolds for the development of anti‐Alzheimer agents. This comprehensive review focuses on the biological evaluation and structure–activity relationship (SAR) trends of benzothiazole derivatives targeting key enzymes and pathways implicated in AD. These include acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), β‐secretase (BACE1), monoamine oxidase A and B (MAO‐A, MAO‐B), receptor‐interacting protein kinase 1 (RIPK1), human DYRK1A (hDYRK1A), and human CLK1 ( h CLK1). Benzothiazole hybrids with diverse heterocyclic frameworks have been explored, and SAR analysis suggests that the presence of electron‐withdrawing substituents in the molecules significantly enhances their potency against Alzheimer's targets. Many of these compounds demonstrate strong in vitro activity, multitarget inhibition potential, and favorable interaction profiles in docking studies, highlighting their relevance as multitarget‐directed ligands. This review consolidates data from the last decade to provide insights into the structural features contributing to anti‐Alzheimer's activity and offers directions for the rational design of more selective, efficacious, and brain‐penetrant benzothiazole derivatives. Future research should focus on optimizing pharmacokinetic properties, improving blood–brain barrier permeability, and validating in vivo efficacy of the designed molecules. Overall, benzothiazole remains a valuable and versatile scaffold in the ongoing search for effective therapeutics for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBenzothiazolesCholinesterase InhibitorsNeuroprotective AgentsHumansStructure-Activity RelationshipAnimalsAcetylcholinesteraseButyrylcholinesteraseMonoamine OxidaseMonoamine Oxidase Inhibitors

Stichwörter der Autor:innen

Anti‐Alzheimer's agentsButyrylcholinesterase inhibitorsacetyl cholinesterase inhibitorsbenzothiazolesmolecular docking

Substanzen

BenzothiazolesCholinesterase InhibitorsbenzothiazoleAcetylcholinesteraseButyrylcholinesteraseNeuroprotective AgentsMonoamine OxidaseMonoamine Oxidase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India.
  • Faculty of Pharmacy, Parul University, Vadodara, Gujarat, India.
  • Research and Development Cell, Parul University, Vadodara, Gujarat, India.

ORCID-Profile: Mange Ram Yadav, Afzal Nagani

Zitieren

APA

Shah, M., Sinha, S., Bhasme, M., Yadav, M. R., & Nagani, A. (2026). Benzothiazole‐Based Anti‐Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025. The Chemical Record, 26(6). https://doi.org/10.1002/tcr.70137

Vancouver

Shah M, Sinha S, Bhasme M, Yadav MR, Nagani A. Benzothiazole‐Based Anti‐Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025. The Chemical Record. 2026;26(6). doi:10.1002/tcr.70137

BibTeX
@article{Shah2026,
  author = {Shah, Moksh and Sinha, Sudhanshu and Bhasme, Meetali and Yadav, Mange Ram and Nagani, Afzal},
  title = {Benzothiazole‐Based Anti‐Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025},
  journal = {The Chemical Record},
  year = {2026},
  volume = {26},
  number = {6},
  doi = {10.1002/tcr.70137}
}
Kostenlos starten →